Issue Date: January 8, 2007
Actavis Acquires Indian Drug Facility
Icelandic generic drugmaker Actavis has bought a manufacturing plant in Alathur, India, from the Indian firm Grandix Pharmaceuticals. The site manufactures solid oral dosage formulations of drugs. Actavis notes that it recently opened an active pharmaceutical ingredient development facility in India, and in 2005 it acquired Lotus Laboratories, a Bangalore-based contract research organization.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society